Yu Shan Hsieh Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

9/2019

Linalyl acetate prevents three related factors of vascular damage in COPD-like and hypertensive rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu Shan Hsieh Research Topics

Disease

4	Hypertension (High Blood Pressure) 01/2020 - 01/2018
3	Body Weight (Weight, Body) 09/2021 - 01/2018
1	Ulcerative Colitis 01/2022
1	Experimental Arthritis 09/2021
1	Rheumatoid Arthritis 09/2021
1	Insulin Resistance 11/2020
1	Type 2 Diabetes Mellitus (MODY) 11/2020
1	Cognitive Dysfunction 01/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 09/2019
1	Diarrhea 06/2018
1	Ischemic Stroke 01/2018

Drug/Important Bio-Agent (IBA)

5	linalyl acetateIBA 01/2022 - 01/2018
3	Nicotine FDA Link 09/2021 - 06/2018
2	NADPH Oxidases (NAD(P)H oxidase)IBA 09/2019 - 01/2018
1	lavender oilIBA 01/2022
1	InterleukinsIBA 09/2021
1	Insulin-Like PeptidesIBA 09/2021
1	Matrix Metalloproteinases (MMPs)IBA 11/2020
1	CorticosteroneIBA 11/2020
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2020
1	Dietary Fats (Dietary Fat)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 09/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2019
1	lancemaside AIBA 09/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2019
1	olmesartanIBA 06/2018
1	NitritesIBA 01/2018
1	Antihypertensive Agents (Antihypertensives)IBA 01/2018
1	Therapeutic UsesIBA 01/2018